PCLO Stock Overview
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
PharmaCielo Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.17 |
| 52 Week High | CA$0.29 |
| 52 Week Low | CA$0.10 |
| Beta | 2.48 |
| 1 Month Change | -2.94% |
| 3 Month Change | -15.38% |
| 1 Year Change | -23.26% |
| 3 Year Change | -88.78% |
| 5 Year Change | -98.12% |
| Change since IPO | -97.18% |
Recent News & Updates
Recent updates
Is PharmaCielo (CVE:PCLO) Using Too Much Debt?
Oct 04
Is PharmaCielo (CVE:PCLO) Using Too Much Debt?
Feb 25PharmaCielo (CVE:PCLO) Is Making Moderate Use Of Debt
Aug 03Is PharmaCielo (CVE:PCLO) Weighed On By Its Debt Load?
Dec 23Is PharmaCielo (CVE:PCLO) A Risky Investment?
May 14Should PharmaCielo (CVE:PCLO) Be Disappointed With Their 9.8% Profit?
Feb 16Shareholder Returns
| PCLO | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -2.9% | -3.9% | 1.2% |
| 1Y | -23.3% | 53.0% | 6.1% |
Return vs Industry: PCLO underperformed the Canadian Pharmaceuticals industry which returned 53% over the past year.
Return vs Market: PCLO underperformed the Canadian Market which returned 6.1% over the past year.
Price Volatility
| PCLO volatility | |
|---|---|
| PCLO Average Weekly Movement | 15.9% |
| Pharmaceuticals Industry Average Movement | 13.8% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: PCLO's share price has been volatile over the past 3 months.
Volatility Over Time: PCLO's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Marc Lustig | www.pharmacielo.com |
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia.
PharmaCielo Ltd. Fundamentals Summary
| PCLO fundamental statistics | |
|---|---|
| Market cap | CA$28.01m |
| Earnings (TTM) | -CA$12.82m |
| Revenue (TTM) | CA$2.81m |
10.0x
P/S Ratio-2.2x
P/E RatioIs PCLO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PCLO income statement (TTM) | |
|---|---|
| Revenue | CA$2.81m |
| Cost of Revenue | CA$3.55m |
| Gross Profit | -CA$737.25k |
| Other Expenses | CA$12.08m |
| Earnings | -CA$12.82m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.076 |
| Gross Margin | -26.23% |
| Net Profit Margin | -456.04% |
| Debt/Equity Ratio | 599.3% |
How did PCLO perform over the long term?
See historical performance and comparison